Skip to content
DataLookout
Menu

NCT07557706

Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease

StatusRecruiting
PhasePhase 1
Primary completion (estimated)

At risk: Primary completion moved 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates pushed to Jul 31, 2027 Show 4 more changesShow less
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 4 of 5 entries
    • Site contact updated
    • Publications: details revised at 1 of 1 entry
  2. Notable Phase changed: Not applicable → Phase 1v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change in heart rate
Timeframe: During Visit 2 and Visit 3 (1-2 weeks after baseline, with 48 hour wash-out between visits 2 and 3), during and following 15 minutes of stimulation.
Change in blood pressure
Timeframe: During Visit 2 and Visit 3 (1-2 weeks after baseline, with 48 hour wash-out between visits 2 and 3), during and following 15 minutes of stimulation.

Secondary (5)

Skin temperature
Autonomic Symptom Burden (COMPASS-31)
Autonomic Symptom Severity (SCOPA-AUT)
Physical Activity (Goodin Leisure-Time Exercise Questionnaire)
Physical Activity (International Physical Activity Questionnaire)

Arms and interventions

Group 1Experimental

Active taVNS on Visit 2, Sham taVNS on Visit 3. Active taVNS is delivered at 30 Hz, 250 µs, 0.1-4 mA for 15 minutes. Sham taVNS is delivered at 0 mA output for 15 minutes. A minimum washout period of 48 hours will be observed between visits.

Group 2Experimental

Sham taVNS on Visit 2, Active taVNS on Visit 3. Active taVNS is delivered at 30 Hz, 250 µs, 1-4 mA for 15 minutes. Sham taVNS is delivered at 0 mA output for 15 minutes. A minimum washout period of 48 hours will be observed between visits

Devices: transcutaneous auricular vagus nerve stimulation

Sites

1 site in 1 country

  • Wellness, Health and Research Facility at UABBirmingham, Alabama, United States